Skip to main content
FinSpry Logo
FinSpry
IKT logo
IKT
(NASDAQ)
Inhibikase Therapeutics, Inc.
$2.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Inhibikase Therapeutics (IKT) Stock Price & Financial Analysis

Inhibikase Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.48 - $2.55
52-Week High$2.61
52-Week Low$1.33
Open$2.49
Volume245.96K
Average Volume (3M)478.82K
Market Cap245.78M
Shares Outstanding98.31M
Price to Book (P/B)1.47
EV/EBITDA-3.64
50-Day MA$2.27
200-Day MA$1.88
52-Week Change49.70%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Inhibikase Therapeutics

What is the current stock price for IKT?

As of the latest trading session, IKT stock trades at $2.50. The 52-week range is $1.33–$2.61, with a day range of $2.48–$2.55.

What is the P/E ratio for IKT?

The P/E ratio (Price-to-Earnings) for IKT is shown in the Key Statistics section. This valuation metric helps compare Inhibikase Therapeutics, Inc. to industry peers.

Does IKT pay dividends?

Inhibikase Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IKT?

Based on 1 analyst, the consensus for IKT is Buy.

What is the market cap of IKT?

Inhibikase Therapeutics's market capitalization is $245.8M, classifying it as a micro-cap company. Inhibikase Therapeutics operates in the Healthcare sector within the Biotechnology industry.